Guide price only. Final cost is confirmed after assessment.
uFat Regenerative Therapy is a groundbreaking advancement in regenerative medicine. At London Cartilage Clinic, we utilise this cutting-edge technique, focusing on the gentle processing of adipose tissue to preserve mesenchymal Stem Cell / Medicinal Signaling Cells, enhancing the body's natural healing process. uFat therapy stands out for its ability to maintain the integrity of adipose tissue, offering superior regenerative capabilities compared to traditional methods.
uFat focuses on gentle adipose processing to better preserve cellular architecture and stromal vascular niches that support tissue repair.
uFat and mFat are both valuable; selection depends on tissue target, required potency, and treatment objectives.
uFat is minimally invasive and designed to deliver regenerative tissue support with less disruption than more aggressive processing techniques.
At London Cartilage Clinic, uFat is integrated into a full care plan that includes diagnosis, procedural precision, and follow-up to track clinical response.
uFat therapy differs in its focus on preserving the structural integrity and cellular composition of adipose tissue. This results in a product richer in mesenchymal Stem Cell / Medicinal Signaling Cells, offering more potent regenerative properties.
uFat therapy is effective for a variety of conditions, including osteoarthritis, tissue injuries, and in cosmetic applications for tissue regeneration and anti-aging treatments.
Recovery times for uFat therapy are typically minimal, with most patients resuming normal activities within a short period. However, the specific recovery time can vary depending on the individual case.
Still have more specific concerns?
Free Discovery CallLondon Cartilage Clinic
Clinical updates, cartilage treatment guidance, and recovery-focused articles from our specialist team.
ChondroFiller injection has produced no serious adverse effects across 19,000+ clinical cases since 2013; the complaint rate stands at 0.06%, among the lowest in cartilage repair. Post-injection swelling, pain, and stiffness resolve within 48–72 hours, but follow-up data beyond three years remain sparse.
In roughly half of ACL ruptures, articular cartilage sustains damage at the moment of rupture. The joint's inflammatory cascade thereafter actively degrades cartilage matrix, which cannot self-repair; this initiates osteoarthritis typically a decade earlier than in uninjured peers.
Functional recovery from ChondroFiller outpaces structural repair: patients achieve a clinically meaningful 30-point IKDC improvement within twelve months, but cartilage maturation on MRI continues beyond that functional plateau.
